Abstract
In connection to our previously reported phosphine compounds as antitumor agents, this article describes the preparation of ferrocenyl amino-phosphine and their possible cytotoxic potential towards the human hepatocellular carcinoma cell line Hep3B. The preliminary results suggested that ferrocenyl amino-phosphines can be potential anti-tumour agents which might be considered as novel cancer chemotherapeutic agents. In particular, compounds 4b, 4d and 4f exhibit strong cytotoxicity with IC50< 5 μg ml-1. These compounds possess more promising cytotoxic activities than their precursor non-substituted ferrocene as well as the reference metallodrug cisplatin.
| Original language | English |
|---|---|
| Pages (from-to) | 881-885 |
| Number of pages | 5 |
| Journal | MedChemComm |
| Volume | 2 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - 1 Sept 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Biochemistry
- Pharmaceutical Science
Fingerprint
Dive into the research topics of 'Enantioselective preparation of ferrocenyl amino phosphines and their cytotoxic activities'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver